Big Pharma Strategies for Biologics Catch-Up
By Business Review Editor
Pharma Deals Review: Vol 2008 Issue 91 (Table of Contents)
Published: 1 Jan-2008
DOI: 10.3833/pdr.v2008.i91.235 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The healthcare industry is based on a history of small molecule therapeutics, but, today, the industry#8217;s potential is considered by many to lie in biologics, although the majority of therapeutic drug sales are still for small molecules...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018